Literature DB >> 2027484

Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction.

S M Rao1, G J Leo, L Bernardin, F Unverzagt.   

Abstract

Previous frequency estimates of cognitive dysfunction in multiple sclerosis have ranged from 54 to 65 percent. These studies may overestimate the frequency in the general MS population, since the patients in these studies were recruited from clinic populations. In the present study, we administered a comprehensive neuropsychological test battery to 100 community-based MS patients and 100 demographically matched healthy controls. Of 31 cognitive test indices examined, 48 MS patients and five controls were impaired on four or more test indices, yielding an overall frequency rate of 43% for the MS group. The pattern of cognitive decline was not uniform: MS patients were more frequently impaired on measures of recent memory, sustained attention, verbal fluency, conceptual reasoning, and visuospatial perception, and less frequently impaired on measures of language and immediate and remote memory. We developed a brief (20-minute) screening battery empirically by selecting the four most sensitive test indices from the comprehensive battery. The brief battery yielded a sensitivity value of 71% and a specificity value of 94% in discriminating cognitively intact from impaired MS patients, as defined by the comprehensive battery. Cognitive impairment was not significantly associated with illness duration, depression, disease course, or medication usage, but was significantly (albeit weakly) correlated with physical disability.

Entities:  

Mesh:

Year:  1991        PMID: 2027484     DOI: 10.1212/wnl.41.5.685

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  454 in total

1.  Optimism and adaptation to multiple sclerosis: what does optimism mean?

Authors:  M Fournier; D de Ridder; J Bensing
Journal:  J Behav Med       Date:  1999-08

2.  Validity of a computerized version of the symbol digit modalities test in multiple sclerosis.

Authors:  Nadine Akbar; Kimia Honarmand; Nancy Kou; Anthony Feinstein
Journal:  J Neurol       Date:  2010-10-06       Impact factor: 4.849

3.  Non-Gaussian diffusion MRI of gray matter is associated with cognitive impairment in multiple sclerosis.

Authors:  M Bester; J H Jensen; J S Babb; A Tabesh; L Miles; J Herbert; R I Grossman; M Inglese
Journal:  Mult Scler       Date:  2014-11-12       Impact factor: 6.312

4.  Randomized controlled trial of physical activity, cognition, and walking in multiple sclerosis.

Authors:  Brian M Sandroff; Rachel E Klaren; Lara A Pilutti; Deirdre Dlugonski; Ralph H B Benedict; Robert W Motl
Journal:  J Neurol       Date:  2013-12-10       Impact factor: 4.849

5.  Self-efficacy as a predictor of self-reported physical, cognitive, and social functioning in multiple sclerosis.

Authors:  Margaret M Schmitt; Yael Goverover; John Deluca; Nancy Chiaravalloti
Journal:  Rehabil Psychol       Date:  2013-12-09

Review 6.  Mechanisms of action of ACTH in the management of relapsing forms of multiple sclerosis.

Authors:  Regina Berkovich; Mark A Agius
Journal:  Ther Adv Neurol Disord       Date:  2014-03       Impact factor: 6.570

7.  Visual search as a tool for a quick and reliable assessment of cognitive functions in patients with multiple sclerosis.

Authors:  Kathrin S Utz; Thomas M A Hankeln; Lena Jung; Alexandra Lämmer; Anne Waschbisch; De-Hyung Lee; Ralf A Linker; Thomas Schenk
Journal:  PLoS One       Date:  2013-11-25       Impact factor: 3.240

8.  Cognitive impairment in probable multiple sclerosis.

Authors:  A Achiron; Y Barak
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-04       Impact factor: 10.154

9.  Validity of the Verbal Concept Attainment Test in multiple sclerosis.

Authors:  Ryan Mulligan; Michael R Basso; Lily Lau; Bradley Reynolds; Douglas M Whiteside; Dennis Combs; Robert A Bornstein
Journal:  J Clin Exp Neuropsychol       Date:  2019-01-14       Impact factor: 2.475

10.  A simple measure of cognitive reserve is relevant for cognitive performance in MS patients.

Authors:  Marida Della Corte; Gabriella Santangelo; Alvino Bisecco; Rosaria Sacco; Mattia Siciliano; Alessandro d'Ambrosio; Renato Docimo; Teresa Cuomo; Luigi Lavorgna; Simona Bonavita; Gioacchino Tedeschi; Antonio Gallo
Journal:  Neurol Sci       Date:  2018-05-04       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.